A phase I single ascending dose clinical trial of VTP-45489 in normal healthy volunteers
Latest Information Update: 17 Aug 2016
At a glance
- Drugs VTP 45489 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- 17 Aug 2016 New trial record
- 03 Aug 2016 According to a Vitae Pharmaceuticals media release, the company expects to initiate this trial during the third quarter of 2016.